Iniciar Sesión Regístrate abrir menu

Bibliografía Científica

Artículos por temáticas

En este apartado encontrará una actualización mensual de Trastornos del Movimiento

4405 ARTÍCULOS , VIENDO DEL 1981 AL 1995

Advanced Parkinson's or "complex phase" Parkinson's disease? Re-evaluation is needed

Titova N, Martinez-Martin P, Katunina E, Chaudhuri KR.

J Neural Transm (Vienna). 2017 Dec;124(12):1529-1537. doi: 10.1007/s00702-017-1799-3. Epub 2017 Nov 7.

Advances in Roles of miR-132 in the Nervous System

Qian Y, Song J, Ouyang Y, Han Q, Chen W, Zhao X, Xie Y, Chen Y, Yuan W, Fan C.

Front Pharmacol. 2017 Oct 25;8:770. doi: 10.3389/fphar.2017.00770. eCollection 2017.

Minimizing nocebo effect: Pragmatic approach

Chamsi-Pasha M, Albar MA, Chamsi-Pasha H.

Avicenna J Med. 2017 Oct-Dec;7(4):139-143. doi: 10.4103/ajm.AJM_59_17.

Closing the celebration of 200 years of Parkinson's Essay on the Shaking Palsy: Where do we go in the next 200 years?

Goetz CG.

Mov Disord. 2017 Dec;32(12):1651-1652. doi: 10.1002/mds.27214. Epub 2017 Nov 9.

Be vigilant for dementia in Parkinson’s disease

Niccolini F, Diamantopoulos K, Kiosses S, Politis M.

Practitioner. 2017 May;261(1804):11-5.

Impact of inability to turn in bed assessed by a wearable three-axis accelerometer on patients with Parkinson's disease

Uchino K, Shiraishi M, Tanaka K, Akamatsu M, Hasegawa Y.

PLoS One. 2017 Nov 9;12(11):e0187616. doi: 10.1371/journal.pone.0187616. eCollection 2017.

A mixed methods evaluation of a Mindfulness-Based Stress Reduction course for people with Parkinson's disease

Birtwell K, Dubrow-Marshall L, Dubrow-Marshall R, Duerden T, Dunn A.

Complement Ther Clin Pract. 2017 Nov;29:220-228. doi: 10.1016/j.ctcp.2017.10.009. Epub 2017 Oct 25.

Neuropathology of genetic synucleinopathies with parkinsonism: Review of the literature

Schneider SA, Alcalay RN.

Mov Disord. 2017 Nov;32(11):1504-1523. doi: 10.1002/mds.27193.

Generation of induced pluripotent stem cell line (ZZUi005-A) from a 21-year-old patient with a novel RAB39B gene mutation in X-linked juvenile parkinsonism

Wang Y, Sun H, Wang Z, Yang Z, Shi M, Yang J, Liu Y, Liu H, Zhang S, Shi C, Xu Y.

Stem Cell Res. 2017 Dec;25:132-135. doi: 10.1016/j.scr.2017.10.021. Epub 2017 Nov 3.

[Heparan sulphates, amyloidosis and neurodegeneration]

Vera C, Alvarez-Orozco JA, Maiza A, Chantepie S, Chehin RN, Ouidja MO, Papy-Garcia D.

Rev Neurol. 2017 Nov 16;65(10):457-468.

NADPH oxidases in Parkinson's disease: a systematic review

Belarbi K, Cuvelier E, Destée A, Gressier B, Chartier-Harlin MC.

Mol Neurodegener. 2017 Nov 13;12(1):84. doi: 10.1186/s13024-017-0225-5.

Nanoformulation: A Useful Therapeutic Strategy for Improving Neuroprotection and the Neurorestorative Potential in Experimental Models of Parkinson's Disease

Lafuente JV, Requejo C, Carrasco A, Bengoetxea H.

Int Rev Neurobiol. 2017;137:99-122. doi: 10.1016/bs.irn.2017.09.003. Epub 2017 Oct 20.

Referral practice, reporting standards, and the impact of dopamine transporter scans done in a tertiary hospital

Bhattacharjee S, Chalissery AJ, Barry T, O'Sullivan D, O'Connell M, Lynch T.

Neurol India. 2017 Nov-Dec;65(6):1264-1270. doi: 10.4103/0028-3886.217946.

Extracellular Vesicles in Neurodegenerative Diseases: A Double-Edged Sword

Lee JY, Kim HS.

Tissue Eng Regen Med. 2017 Nov 15;14(6):667-678. doi: 10.1007/s13770-017-0090-x. eCollection 2017 Dec.

Actualización mensual Regístrese para recibir los avisos de actualización

Si quiere recomendar un artículo/publicación para completar este apartado puede hacerlo a través del formulario de contacto para su valoración.

En ningún caso la información facilitada constituye asesoramiento por parte de Zambon

Con el aval de:

Logo SEN Logo WIS

En colaboración con:

Zambon Neurociencias